ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, TNF Pharmaceuticals, Inc. (TNFA) shows an Average True Range (ATR) of 0.02 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 24.8M, indicating liquidity. These fundamental metrics provide insight into TNFA's underlying financial health and market activity.
TNF Pharmaceuticals, Inc. (TNFA) technical indicators as of July 31, 2025: the SMA 20 is 7.73%, SMA 50 at -10.51%, and SMA 200 at -81.46%. The RSI 14 value is 49.55, suggesting its current momentum. These technical analysis signals help assess TNFA's price trends and potential future movements.
TNF Pharmaceuticals, Inc. (TNFA) stock performance overview as of July 31, 2025: The 52-week high is $2.16 (currently -94.21% below), and the 52-week low is $0.085 (currently 47.23% above). Over the past year, TNFA's performance is -93.28%, compared to the S&P 500's 15.22% change.
According to market data, TNF Pharmaceuticals, Inc. (TNFA) stock's recent performance metrics show that over the last month, TNFA is 1.79%, with a Year-to-Date (YTD) performance of -89.13%. Over the past year, the stock has seen a -93.28% change. These figures summarize TNFA's price movements across various periods, reflecting its historical returns.
According to current financial data, TNFA stock's P/E (TTM) ratio is -0.04, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for TNFA, including P/S (N/A), P/B (0.05), and P/FCF (-0.18), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.